Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius

Veterinary Dermatology

Volumn 23, Issue 4, 2012, Pages

  Gebru Awji, Elias ^a   Tassew, Dereje Damte ^a   Lee, Joong Su ^a   Lee, Seung Jin ^a   Choi, Myung Jin ^a   Reza, Mohammad Ahsanur ^a   Rhee, Man Hee ^a   Kim, Tae Hwan ^a   Park, Seung Chun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLASSIFICATION; DOG; DOSE RESPONSE; DRUG EFFECT; GENETICS; MICROBIAL SENSITIVITY TEST; MUTATION; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84864116177     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01038.x     Document Type: Article

References (19)

1. Mueller RS, Stephan B. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial. Vet Dermatol 2007; 18: 144-151.
2. Yoo JH, Yoon JW, Lee SY et al. High prevalence of fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. J Microbiol Biotechnol 2010; 20: 798-802.
3. Hanselman BA, Kruth SA, Rousseau J et al. Coagulase positive staphylococcal colonization of humans and their household pets. Can Vet J 2009; 50: 954-958.
4. Youn JH, Hwang SY, Kim SH et al. mecA gene transferrability and antibiogram of zoonotic Staphylococcus intermedius from animals, staff, and the environment in animal hospitals in Korea. J Microbiol Biotechnol 2010; 20: 425-432.
5. Boothe DM, Boeckh A, Simpson RB et al. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy of 5 fluoroquinolones toward pathogens of dogs and cats. J Vet Intern Med 2006; 20: 1297-1306.
6. Blondeau JM, Zhao X, Hansen G et al. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 433-438.
7. Drlica K, Zhao X. Mutant selection window hypothesis updated. Clin Infect Dis 2007; 44: 681-688.
8. Liu Y, Cui J, Wang R et al. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance. J Antimicrob Chemother 2005; 56: 1172-1175.
9. Drlica K. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 2003; 52: 11-17.
10. Baron F, Cochet M, Pellerini JL et al. Development of a PCR test to differentiate between Staphylococcus aureus and Staphylococcus intermedius. J Food Prot 2004; 67: 2302-2305.
11. Bannoehr J, Franco A, Lurescia M. Molecular diagnostic identification of Staphylococcus pseudintermedius. J Clin Microbiol 2009; 47: 469-471.
12. Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. M31-A3. In: CLSI (Formerly NCCLS) Standards and Guidelines. Wayne, PA: National Committee for Clinical Laboratory Standards, 2008; 1-99.
13. Firsov AA, Vostrov SN, Lubenko IY et al. In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 1604-1613.
14. Intorre L, Vanni M, Di Bello D et al. Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. J Vet Pharmacol Ther 2007; 30: 464-469.
15. Descloux S, Rossano A, Perreten V. Characterization of new staphylococcal cassette chromosome mec (SCCmec) and topoisomerase genes in fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius. J Clin Microbiol 2008; 46: 1818-1823.
16. Craigmill AL, Riviere JE, Webb AI. Tabulation of Farad Comparative and Veterinary Pharmacokinetic Data. Ames, IA: Blackwell Publishing, 2006: 719-859.
17. Cui J, Liu Y, Wang R et al. The mutant selection window demonstrated in rabbits infected with Staphylococcus aureus. J Infect Dis 2006; 194: 1601-1608.
18. Toutain PL, Del Castillo JRE, Bousquet-Mélou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage-regimen for antibiotics. Res Vet Sci 2002; 73: 105-114.
19. Gebru E, Lee JS, Chang ZQ et al. Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration. Antimicrob Agents Chemother 2009; 53: 3024-3029.